Date: 2013-10-10
Type of information: Collaboration agreement
Compound:
Company: Genepep (France) BCN Peptides (Spain)
Therapeutic area:
Type agreement: collaboration
Action mechanism:
Disease:
Details: * On October 10, 2013, BCN Peptides and Genepep have announced a strategic partnership to extend both companies capabilities towards synthetic peptides process development and manufacturing services on behalf of their clients. BCN Peptides is serving its worldwide customers range with GMP-compliant clinical and commercial grade peptide API’s for pharmaceutical and veterinary use, while Genepep specializes in the development of innovative chemistry applied to peptides, peptide libraries and proteins for therapeutic and diagnostic applications. The expertise, know-how and proprietary technologies portfolio of both companies, in addition to their close geographic proximity, will provide customers with a wide range of capabilities and expertise. This will serve the needs of innovative products from research and pre-clinical stage throughout clinical development and registration phases as well as during the successive life cycle phases of the products. The close collaboration and aligned technical solutions between the expert teams of both companies will allow a seamless transition from one group to the other during scaling-up.
Financial terms:
Latest news:
